BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11806505)

  • 21. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermoscopy of Lymphomas and Pseudolymphomas.
    Bombonato C; Pampena R; Lallas A; Giovanni P; Longo C
    Dermatol Clin; 2018 Oct; 36(4):377-388. PubMed ID: 30201147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
    Han B; Liu H; Wang H
    Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The skin-associated lymphoid tissue-related B-cell lymphomas.
    Pimpinelli N; Santucci M
    Semin Cutan Med Surg; 2000 Jun; 19(2):124-9. PubMed ID: 10892714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
    Levy E; Godet J; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous B-cell lymphoma and lymphoproliferative disorders of skin: current status of pathology and classification.
    Salama S
    Am J Clin Pathol; 2000 Nov; 114 Suppl():S104-28. PubMed ID: 11996165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Item 164--Malignant lymphomas: cutaneous lymphomas].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
    [No Abstract]   [Full Text] [Related]  

  • 29. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas.
    Schaerer L; Schmid MH; Mueller B; Dummer RG; Burg G; Kempf W
    Am J Dermatopathol; 2000 Apr; 22(2):140-3. PubMed ID: 10770434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
    Magro CM; Momtahen S
    Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
    Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
    Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential diagnosis of pseudolymphomas].
    Steigleder GK
    Z Hautkr; 1984 Jul; 59(14):937-50. PubMed ID: 6475172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation.
    Navarrete-Dechent C; Del Puerto C; Abarzúa-Araya Á; Molgó M; Geller S; Andreani S; Cury-Martins J; Sanches JA; Montoya J; González S; Uribe P
    Int J Dermatol; 2019 Nov; 58(11):1270-1276. PubMed ID: 31347153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
    Cerroni L; Goteri G
    Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous B-cell pseudolymphoma at the site of vaccination.
    Cerroni L; Borroni RG; Massone C; Chott A; Kerl H
    Am J Dermatopathol; 2007 Dec; 29(6):538-42. PubMed ID: 18032948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous follicle center cell lymphoma.
    Cerroni L; Kerl H
    Leuk Lymphoma; 2001; 42(5):891-900. PubMed ID: 11697644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.